1998
DOI: 10.1016/s0014-5793(98)01352-0
|View full text |Cite
|
Sign up to set email alerts
|

ACTA, a fluorescent analogue of thapsigargin, is a potent inhibitor and a conformational probe of skeletal muscle Ca2+‐ATPase

Abstract: Thapsigargin is a highly potent and selective inhibitor of sarco-endoplasmic reticulum (SERCA) family of Ca P+ -ATPases and a useful tool in research concerning the function of intracellular Ca P+ stores. We describe here a novel fluorescent derivative (8-O-(4-aminocinnamoyl)-8-O-debutanoylthapsigargin, termed ACTA) of this compound, acting as a Ca P+ -ATPase inhibitor with a potency approaching that of thapsigargin. Binding of ACTA to the skeletal muscle sarcoplasmic reticulum vesicles results in a strong flu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 25 publications
1
3
0
Order By: Relevance
“…Supporting this, our prior studies show that over-expressing MRP1 in mouse embryo fibroblasts conferred resistance to PABA/NO, suggesting that a toxic glutathione conjugate is effluxed from the cells [6]. In addition, the EC 50 for ThG in tissue culture was in the range of 90–205 nM [28], [29]. Our data show ThG-mediated increase in NO generation with EC 50 ∼85 nM.…”
Section: Discussionsupporting
confidence: 82%
“…Supporting this, our prior studies show that over-expressing MRP1 in mouse embryo fibroblasts conferred resistance to PABA/NO, suggesting that a toxic glutathione conjugate is effluxed from the cells [6]. In addition, the EC 50 for ThG in tissue culture was in the range of 90–205 nM [28], [29]. Our data show ThG-mediated increase in NO generation with EC 50 ∼85 nM.…”
Section: Discussionsupporting
confidence: 82%
“…Here, we provide a solution involving folate conjugation. We recognize efforts from other groups to create thapsigargin derivatives (Hua et al, 1995;Procida et al, 1998), some of which have been advanced to tumor models (Christensen et al, 2009). In one derivative, mipsagargin (G202; Doan et al, 2015), thapsigargin is conjugated to a peptidyl substrate of the proteolytic enzyme prostate-specific membrane antigen for localized delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, high concentrations of free Ca 2ϩ attenuate SERCA inhibition by thapsigargin (Kijima et al, 1991). Interestingly, in this respect, the fluorescent analog 8-O-(4-aminocinnamoyl)-8-O-debutanoylthapsigargin is almost as potent as thapsigargin in inhibiting 45 Ca 2ϩ uptake by rabbit SERCA1-expressing skeletal muscle microsomes (IC 50 ϭ 168 versus 123 nM, respectively), and its fluorescence is sensitive to the E 1 -E 2 conformational equilibrium, thus making it a conformational probe (Procida et al, 1998). This mechanism of action is also consistent with the localization of the thapsigargin-specific binding site on the SERCA within the S3 stalk segment, as shown in chimerical studies (Ma et al, 1999).…”
Section: Pharmacological Modulation Of Smooth Muscle Sr 453mentioning
confidence: 99%